Quantitative Analysis of the Enhanced Permeation and Retention (EPR) Effect

State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines

(2014) Charlene M. Dawidczyk et al.   JOURNAL OF CONTROLLED RELEASE

Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments

(2014) Charlene M. Dawidczyk et al.   Frontiers in Chemistry

A Mathematical Model of the Enhanced Permeability and Retention Effect for Liposome Transport in Solid Tumors

(2013) Shawn Stapleton et al.   PLoS One

Doxil® — The first FDA-approved nano-drug: Lessons learned

(2012) Yechezkel (Chezy) Barenholz   JOURNAL OF CONTROLLED RELEASE

Macromolecular therapeutics in cancer treatment: The EPR effect and beyond

(2012) Hiroshi Maeda   JOURNAL OF CONTROLLED RELEASE

Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities

(2012) Z. Cheng et al.   SCIENCE

The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect

(2010) Jun Fang et al.   ADVANCED DRUG DELIVERY REVIEWS

Three-dimensional analysis of tumour vascular corrosion casts using stereoimaging and micro-computed tomography

(2010) A.A. Folarin et al.   MICROVASCULAR RESEARCH